Boron Neutron Capture Therapy for High-Grade CNS Tumors: Mechanisms, Carriers, and Clinical Progress: A Narrative Review
International Journal of Molecular Sciences · 18.03.2026 · 27 (6) · 2765
DOI: 10.3390/ijms27062765 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.03.2026. Verfasst von Tugce Kutuk und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA. Hauptthemen laut MEDLINE: Boron Neutron Capture Therapy, Central Nervous System Neoplasms, Glioblastoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Boron neutron capture therapy (BNCT) is a biologically targeted, high–linear energy transfer radiotherapy that selectively delivers cytotoxic α-particles to boron-loaded tumor cells and has re-emerged with the development of hospital-compatible accelerator neutron sources and improved boron carriers. We performed a structured literature review of PubMed, Embase, and the Cochrane Library through October 2025 to summarize the radiobiological rationale, boron delivery strategies, and clinical outcomes of BNCT in glioblastoma (GBM) and other high-grade central nervous system tumors. Eligible clinical and translational studies were screened independently, and data on patient populations, boron agents, neutron source technologies, dosimetry, survival, response, and toxicity were extracted. Contemporary series and phase II trials indicate that BNCT is technically feasible and generally well tolerated, with encouraging survival outcomes in selected newly diagnosed and recurrent GBM, meaningful activity in recurrent high-grade meningiomas, and acceptable safety in limited pediatric cohorts. Current practice relies primarily on second-generation carriers such as boronophenylalanine and sodium borocaptate, while third-generation molecular and nanocarrier platforms remain in preclinical development. Overall, BNCT represents a promising high-LET, pharmacologically targeted modality for heavily pretreated and radioresistant CNS tumors, and ongoing prospective studies are needed to define its comparative effectiveness and optimal integration into patient care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
- Department of Radiation Oncology, Basaksehir Cam and Sakura City Hospital, Istanbul 34480, Türkiye.
- Division of Neuro-Oncology, Department of Neurology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
- Department of Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
- Department of Radiation Oncology, Penn State Cancer Institute, Hershey, PA 17033, USA.
- Department of Radiation Oncology, Lynn Cancer Institute, Baptist Health South Florida, Boca Raton, FL 33486, USA.
ORCID-Profile: Ece Atak, Simeng Zhu, Sean S Mahase, Arnab Chakravarti, Joshua D Palmer
Zitieren
APA
Kutuk, T., Atak, E., Harrell, M., Raval, R. R., Fekrmandi, F., Zhu, S., Beyer, S., Singh, P. K., Giglio, P., Mohtashami, H., Wu, K. C., Elder, J. B., Mahase, S. S., Singh, R., Chakravarti, A., & Palmer, J. D. (2026). Boron Neutron Capture Therapy for High-Grade CNS Tumors: Mechanisms, Carriers, and Clinical Progress: A Narrative Review. International Journal of Molecular Sciences, 27(6), 2765. https://doi.org/10.3390/ijms27062765
Vancouver
Kutuk T, Atak E, Harrell M, Raval RR, Fekrmandi F, Zhu S, et al. Boron Neutron Capture Therapy for High-Grade CNS Tumors: Mechanisms, Carriers, and Clinical Progress: A Narrative Review. International Journal of Molecular Sciences. 2026;27(6):2765. doi:10.3390/ijms27062765
BibTeX
@article{Kutuk2026,
author = {Kutuk, Tugce and Atak, Ece and Harrell, Marshall and Raval, Raju R and Fekrmandi, Fatemeh and Zhu, Simeng and Beyer, Sasha and Singh, Pawan K and Giglio, Pierre and Mohtashami, Hamid and Wu, Kyle C and Elder, James Bradley and Mahase, Sean S and Singh, Raj and Chakravarti, Arnab and Palmer, Joshua D},
title = {Boron Neutron Capture Therapy for High-Grade CNS Tumors: Mechanisms, Carriers, and Clinical Progress: A Narrative Review},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {6},
pages = {2765},
doi = {10.3390/ijms27062765}
}
EUVIMED